Spain· ES:114921004
BiResp Spiromax 320 microgramos / 9 microgramos polvo para inhalacion
A medicinal product containing budesonida + formoterol, registered in Spain by Teva Pharma B.V..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- budesonida + formoterol
- Manufacturer
- Teva Pharma B.V.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo72330560EUR 39.56
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Budesonida + formoterol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenAirbufo Forspiro 160 mikrogram/4,5 mikrogram/inhalation Inhalationspulver, avdelad dosSandoz A/S
- CzechiaAIRBUFO FORSPIROSandoz s.r.o., Praha
- United KingdomDuoResp Spiromax 160micrograms/dose / 4.5micrograms/dose dry powder inhalerMawdsley-Brooks & Company Ltd
- FinlandAerocomp ForspiroSandoz A/S
- NetherlandsAirBuFo Forspiro 160/4,5 microgram/dosis, inhalatiepoeder, voorverdeeldSandoz B.V.
- PolandAirbufo ForspiroSandoz GmbH
- United StatesBREYNAMylan Pharmaceuticals Inc.
- IrelandAirBuFo Forspiro 160 microgram/4.5 microgram/dose inhalation powder, pre-dispensedRowex Limited,
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Symbicort, Symbicort Forte Turbohaler
- Belgium · Airbufo Forspiro, Bufomix Easyhaler
- Bulgaria · Airbufo® Forspiro®, Буфомикс Изихалер
- Cyprus · Bufar Easyhaler, Pulmoton
- Czechia · Airbufo Forspiro, Budesonidefformoterol Cipla
- Germany · Airbufo Forspiro, Bufori Easyhaler
- Denmark · Budesonid/Formoterolfumaratdihydrat Cipla, Bufomix Easyhaler
- Estonia · Airbufo Forspiro, Bufomix Easyhaler
- Finland · Bufomix Easyhaler, Symbicort
- France · Budesonide/Formoterol Forspiro Sandoz, Gibiter Easyhaler
- United Kingdom (Northern Ireland) · Duoresp Spiromax, Fobumix Easyhaler
- Greece · Pulmoresp, Pulmoton
- Croatia · Airbufo Forspiro, Symbicort
- Hungary · Bufomix Easyhaler, Pulmalio
- Ireland · Airbufo Forspiro, Bufomix Easyhaler
- Iceland · Biresp Spiromax, Bufomix Easyhaler
- Italy · Budesonide E Formoterolo Cipla, Budesonide Formoterolo
- Liechtenstein · Biresp Spiromax, Duoresp Spiromax
- Lithuania · Bufomix Easyhaler, Symbicort
- Luxembourg · Bufomix Easyhaler, Symbicort
- Latvia · Airbufo Forspiro, Bufomix Easyhaler
- Malta · Airbufo Forspiro, Symbicort
- Netherlands · Airbufo Forspiro, Budesonide/Formoterolfumaraatdihydraat Cipla
- Norway · Airbufo Forspiro, Biresp Spiromax
- Poland · Airbufo Forspiro, Budesonide + Formoterol Cipla
- Portugal · Assieme Turbohaler, Assieme Turbohaler 320/9
- Romania · Airbufo Forspiro, Symbicort
- Sweden · Airbufo Forspiro, Budesonide/Formoterol Cipla
- Slovenia · Airbufo Forspiro, Bufomix Easyhaler
- Slovakia · Bufomix Easyhaler, Symbicort
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc106ae0-36b0-44f6-8ffe-c8070d8f783a GET /v1/drugs/bc106ae0-36b0-44f6-8ffe-c8070d8f783a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1425023840000}",
"nregistro": "114921004",
"substance": "budesonida + formoterol"
}See everything about budesonida + formoterol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.